Stay updated on BI 695501 vs Adalimumab in Active RA Clinical Trial
Sign up to get notified when there's something new on the BI 695501 vs Adalimumab in Active RA Clinical Trial page.

Latest updates to the BI 695501 vs Adalimumab in Active RA Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.6.3 was added and Revision: v3.6.2 was removed, indicating a minor version update to the page. This change affects only the page metadata, not the study details or data.SummaryDifference0.0%

- Check12 days agoChange DetectedThe page revision tag was updated to v3.6.2, replacing the previous v3.6.0 to indicate a minor metadata update to the study record.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now shows a recruitment-closure notice ('No longer looking for participants'), and adds user guidance sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'). It also updates the Interventions header formatting from 'Intervention / Treatment' to 'Intervention/Treatment' and changes the revision footer from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check34 days agoChange DetectedThe page shows Revision: v3.5.5, replacing the previous v3.5.4, indicating an updated version of the page. This update typically reflects minor refinements or fixes rather than substantive content changes.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a minor update to the record's metadata. There are no evident changes to the study details or content based on the provided text.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page’s revision/version label was updated from **v3.5.2** to **v3.5.3**, indicating a minor release of the site software without any change to the displayed study record.SummaryDifference0.0%

Stay in the know with updates to BI 695501 vs Adalimumab in Active RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 695501 vs Adalimumab in Active RA Clinical Trial page.